Outpatient metformin use is associated with reduced severity of COVID-19 disease in adults with overweight or obesity.
Outpatient metformin use is associated with reduced severity of COVID-19 disease in adults with overweight or obesity. J Med Virol. 2021 07; 93(7):4273-4279.